Mounjaro Diaries: What Happens Week by Week on Treatment

What does the first week on Mounjaro typically feel like?

The first injection is often anticlimactic, which surprises people who've spent weeks reading diaries full of dramatic early changes. That's because 2.5mg (the starting dose) is not designed to produce rapid weight loss. Its job is to let your system adjust to the medicine without being overwhelmed. The prescriber keeps you here for around four weeks before any conversation about moving up begins.

What many people do notice in week one is a quiet shift in appetite. Food becomes slightly less urgent. Some describe a vague fullness that appears earlier in a meal. Others feel little different at all. Nausea is common but tends to be mild at this stage; it's usually worst in the 24–48 hours after the injection and fades as the week goes on. Fatigue and a mild headache appear in some accounts too, these are worth noting but rarely severe enough to interrupt daily life.

The injection itself takes seconds. Most people settle on the same day and rough time each week, which makes it easy to build into a routine, some keep the pen in the fridge door and do it after dinner on a Sunday, which means any early queasiness clears by Monday morning. If you want to follow the experience week by week in more detail, our Mounjaro diary tracks how things typically unfold from the first dose onward. The full clinical picture of tirzepatide explains the dual-mechanism behind these early effects, if you want the detail.

How does the experience change as the dose increases?

This is where most diaries get interesting, and where the picture diverges most between individuals. Each dose step (from 2.5mg to 5mg, 7.5mg, and so on) tends to bring a brief reset of the early side effects. Nausea that had settled at 2.5mg can reappear at 5mg, often for a week or so, then settle again. Understanding this cycle helps; many people who stop treatment do so in that first week after a dose change, not knowing the discomfort is temporary.

Appetite suppression generally deepens with each step. Portions shrink without a conscious decision to restrict them. Some people find certain foods they previously enjoyed become unappealing, particularly very fatty or sweet foods. This is a documented pharmacological effect (tirzepatide slows gastric emptying and acts on appetite-regulating pathways) not a psychological trick. The Mounjaro overview page covers how that mechanism works in plain language.

Weight loss, where it occurs, tends to be most noticeable in the first few months and then continues more gradually. The SURMOUNT-1 trial, published in the New England Journal of Medicine, followed thousands of adults over 72 weeks, average loss at the highest dose was around 20–21% of starting body weight. Individual results varied, as they always do. If you're thinking about whether to move to a higher dose, our page on moving up on Mounjaro walks through what that decision involves.

What do the side effect entries in diaries actually tell you?

Read enough Mounjaro diaries and you'll notice the side effect sections get shorter over time. That's not selection bias, it reflects the clinical reality that GI symptoms tend to be most troublesome early in treatment and after dose increases, and then fade. Nausea, loose stools, constipation, and reflux are the most commonly described. Tiredness appears in some accounts. Injection-site reactions are occasionally mentioned but rarely persistent.

What diary writers sometimes underplay is the value of telling your prescriber when something is bothering you. Dose timing, hydration, meal composition and pace all interact with how the medicine sits. These aren't things to troubleshoot alone. The NHS tirzepatide page lists the common and serious side effects clearly, and it's worth reading before you start. Serious but rare effects (severe stomach pain radiating to the back, signs of an allergic reaction, gallbladder symptoms) require urgent medical attention; that part of the NHS page is not optional reading.

It's also worth knowing that diary accounts, however honest, don't capture clinical nuance. Someone writing about a bad week at 10mg doesn't know whether their nausea was made worse by eating too quickly, a concurrent illness, or a drug interaction. A prescriber does. That's precisely why the most common questions people bring to a consultation tend to be about side effects, and why having access to aftercare matters. If you're not sure what good clinical support looks like, our about page sets out how ours works.

What should you take away from other people's Mounjaro accounts?

Diaries are useful for one thing: normalising the experience. Knowing that week three at a new dose is often the hardest, or that hunger returning briefly doesn't mean the medicine has stopped working, can stop people from making premature decisions. That's genuinely valuable. Some accounts of people's journeys (including the kind collected on our Mounjaro weight-loss stories page) give that texture without overpromising.

What diaries can't do is tell you how you'll respond. Tirzepatide is a prescription medicine precisely because the clinical picture (your health history, other medicines, weight-related conditions, goals) shapes how it should be used and at what pace. No diary replaces that assessment. The weight-loss treatment options page is a good place to understand the broader landscape before you decide.

On cost context: if you've seen prices mentioned in diaries or forums and wondered what to make of them, our guide to getting Mounjaro through a regulated UK pharmacy explains what a legitimate private prescription typically includes and what to watch for. The figure that matters most isn't the headline price, it's whether the pharmacy is registered, the prescription is real, and the clinical support is ongoing. That's a point worth sitting with before anything else.

If you'd like to understand whether tirzepatide might be appropriate for you, speak to our prescribers, a free consultation, reviewed the same day by a GPhC-registered Independent Prescriber, is where that conversation starts.